Development & Validation of Preoperative Objective Physiological Evaluation
POPE
1 other identifier
interventional
100
1 country
1
Brief Summary
This study will compare the measured oxygen consumption (VO2) obtained during sub-maximal exercise testing with the estimated VO2 derived from a non-exercise questionnaire.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 12, 2021
CompletedFirst Posted
Study publicly available on registry
October 25, 2021
CompletedStudy Start
First participant enrolled
November 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
April 27, 2026
April 1, 2026
5.3 years
October 12, 2021
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total amount of oxygen consumed per minute
Oxygen consumption measured in mL/min
Up to 15 minutes
Study Arms (2)
6MST VO2
ACTIVE COMPARATORCompletion of 6MST exercise protocol
DASI VO2
ACTIVE COMPARATORCompletion of DASI fitness activity questionnaire
Interventions
Eligibility Criteria
You may qualify if:
- Age 18 and older
- Able to speak English
- Ambulatory \[assistive devices ok\]
- Preoperative Anesthesia and Surgical Screening (PASS) clinic patient with DASI score \<34
- Able to provide informed consent
You may not qualify if:
- Acute myocardial infarction (3-5 days)
- Unstable angina
- Severe untreated arterial hypertension at rest (\>200 mm Hg systolic, \>120 mm Hg diastolic)
- Resting heart rate \> 120 bpm
- Room air desaturation at rest on room air \<85%
- Inmate of correctional facility (i.e. prisoner)
- Diagnosed history of dementia
- Inability to ambulate independently
- Considered inappropriate to participate by Principal Investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Health System
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David MacLeod, FRCA
Duke University
Central Study Contacts
Ashley Burke, BS
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2021
First Posted
October 25, 2021
Study Start
November 23, 2021
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
April 27, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share